Successful Treatment of Acute Chest Syndrome with Manual Exchange Transfusion in a Patient with Sickle Beta


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Jun 2019
Historique:
pubmed: 5 2 2019
medline: 20 8 2019
entrez: 5 2 2019
Statut: ppublish

Résumé

Acute chest syndrome (ACS), characterized by fever, respiratory symptoms, and new pulmonary infiltration, is a serious complication of sickle cell disease (SCD). Regardless of the etiology, the conventional treatment options for ACS include empirical antibiotic therapy, the administration of analgesics, and red cell transfusion. The indications and methods of red cell transfusion are critical. We herein report the case of a 26-year-old African-American man with SCD who developed ACS and who was successfully treated with manual exchange transfusion. Despite increasing globalization, SCD remains extremely rare in Japan. Manual exchange transfusion can be performed easily anywhere and should be considered for treating SCD patients presenting with ACS.

Identifiants

pubmed: 30713307
doi: 10.2169/internalmedicine.1753-18
pmc: PMC6599936
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

1629-1634

Références

N Engl J Med. 1999 Jul 8;341(2):99-109
pubmed: 10395635
N Engl J Med. 2000 Jun 22;342(25):1855-65
pubmed: 10861320
Crit Pathw Cardiol. 2008 Jun;7(2):133-8
pubmed: 18520531
Br J Haematol. 1991 Mar;77(3):386-91
pubmed: 2012764
J Thromb Thrombolysis. 2013 Apr;35(3):352-8
pubmed: 23435703
Br J Haematol. 2015 May;169(4):492-505
pubmed: 25824256
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7051-4
pubmed: 25941403
Hemoglobin. 2015;39(6):375-9
pubmed: 26287797
Am J Hematol. 2016 Feb;91(2):173-8
pubmed: 26492581
Br J Haematol. 2017 Jan;176(2):192-209
pubmed: 27858994
N Engl J Med. 2017 Apr 20;376(16):1561-1573
pubmed: 28423290
Br J Haematol. 2018 Feb;180(4):607-617
pubmed: 29377071
N Engl J Med. 1973 Jan 4;288(1):31-3
pubmed: 4681897
Lancet. 1984 Jan 7;1(8367):36-8
pubmed: 6140352
Blood. 1994 Jul 15;84(2):643-9
pubmed: 7517723
N Engl J Med. 1994 Jun 9;330(23):1639-44
pubmed: 7993409
Am J Med. 1994 Feb;96(2):155-62
pubmed: 8109600
Arch Intern Med. 1994 Mar 14;154(5):557-61
pubmed: 8122949
Blood. 1997 Mar 1;89(5):1787-92
pubmed: 9057664
N Engl J Med. 1997 Sep 11;337(11):762-9
pubmed: 9287233

Auteurs

Akihiro Kawahara (A)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Takehiko Morioka (T)

Department of Hematology, Hiroshima University Hospital, Japan.

Yuichiro Otani (Y)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Keishi Kanno (K)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Taro Edahiro (T)

Department of Hematology, Hiroshima University Hospital, Japan.

Noriyasu Fukushima (N)

Department of Hematology, Hiroshima University Hospital, Japan.
Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan.

Sachi Nagasaka (S)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Mika Housai (M)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Masaki Kakimoto (M)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Naoki Tsuji (N)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Shuntaro Asano (S)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Yuka Kikuchi (Y)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Tomoki Kobayashi (T)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Daisuke Miyamori (D)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Ryoko Ishida (R)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Kazuki Kimura (K)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Nobusuke Kishikawa (N)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Masafumi Mizooka (M)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Tatsuo Ichinohe (T)

Department of Hematology, Hiroshima University Hospital, Japan.
Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan.

Susumu Tazuma (S)

Department of General Internal Medicine, Hiroshima University Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH